Navigation Links
Hookworms in MS trial
Date:3/3/2009

>MS affects more than 85,000 people in the UK and several million worldwide. Symptoms range from loss of sight and mobility, fatigue, depression and cognitive problems that often come on as attack - or relapses. There is no cure and few effective treatments.

Dorothy Sutton, 58, from Awsworth, has lived with MS for 32 years and is a Helpline volunteer for the MS Society. She said that although the treatment sounded unusual, anything that could potentially to help alleviate the symptoms of MS is a positive step.

"We have to explore every avenue of research to find treatments for MS. As long as it's safe and effective in helping the horrible symptoms, I don't think people mind where it comes from."

The Division of Clinical Neurology at The University of Nottingham's Medical School is a strong research-led unit which draws heavily on its close relationship with people with MS to inform its work.

Led by Professor Cris Constantinescu, the department features two academic and one NHS Neurology Consultants that are affiliated with the Neuroscience Directorate of Nottingham University Hospitals (NUH) NHS Trusts.


'/>"/>

Contact: Professor Cris Constantinescu
cris.constantinescu@nottingham.ac.uk
44-011-584-66597
University of Nottingham
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
2. CANTAM first African Network of Excellence for clinical trials
3. Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials
4. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
5. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
6. Laser Therapy Disappoints in Stroke Trial
7. Landmark Trial Provides Vital Information for Cardiac Disease Treatment
8. Many Clinical Trials Moving Overseas
9. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
10. Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology
11. Bradmer provides clinical trial update and announces evaluation of strategic alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...z., Dec. 4 Healthcare Trust of Ame...al estate investment trust, announced the executio...ree building medical office portfolio located in S..., Indiana for approximately $20,500,000. The clos...ion of a number of conditions. ,, The approxima...
(Date:12/4/2009)...ec. 4 While Congress de...lth care costs, Leapfrog,s purchaser members point...vering the best quality care in the nation while a...four urban, eight children,s and three rural hospi...based on results from The Leapfrog Hospital Survey...
(Date:12/4/2009)...ntists at Johns Hopkins publishing in the December...de by a gene called "Twist" may be the proverbial ...s that drive aggressive, metastatic breast cancer ...cent work suggesting that it is a relatively rare ...s breast cancer, scientists have surmised that thi...
(Date:12/4/2009)...ental tourism is a phenomenon that was started by ... high price of dental work in the US, Canada, and ...dental care, people have found that Mexican Dental...stination. , (PRWEB) Dece...han 6 years, Mexican Dental Vacation is seeing the...
(Date:12/4/2009)...PRNewswire/ -- Substantial progress has been made ...,s ability to diagnose and treat epilepsy and its ...gement has not reached most of the 50 million peop...three million people in the United States who have...ter, M.D., president of the American Epilepsy Soci...
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4
...t nurses could be bustling around hospital wards i...s in Germany who have developed ground-breaking so...eveloped by the EU-funded scientists will perform ...onitor the temperature of patients remotely with l...
...nesp an anemia drug from Amgen Inc disclosed a ris...r patients. This has reiterated the fact// that su...ions only. The mode of action of Aranesp is ba...ct of Amgen Inc and has also been permitted to tre...
... study in the February issue of Radiology, a novel... Angiography is highly accurate in identifying blo...rain. "Contrast-enhanced MR Angiography pro... School of Medicine at UCLA in Los Angeles. "MR An...
...rchers have disclosed that suppression of an enzym...c type of breast cancer//. This study was conducte...ed to develop into a breast cancer condition of hu...ind of breast cancer linked to ERBB2 gene. In this...
...ody of leading public health experts said that NHS...treatments and drop all prescription charges//. P... routine operations – they said. Dr. Tim Crayf...ay for certain types of non-emergency surgeries li...
...s been tested in Australia for Type 2 Diabetes app...m to bring their blood sugar under control// but a...sed by Stephen Twigg who is an associate Professor... by the pancreas in type 2 diabetes. The general m...
Other Medicine News:Health News:Robot Nurses Ready For Hospitals 'In Three Years' 2Health News:MR Angiography Detects Blocked Arteries Accurately 2
(Date:12/4/2009)...RISTOWN, N.J., Dec. 4 Wa...ng global specialty pharmaceutical company, today ..., Inc.-Florida, filed an Abbreviated New Drug Appl...tration seeking approval to market its 8mg ramelte...ed by Takeda Pharmaceutical Company Limited. Wats...
(Date:12/4/2009)...INGTON, Del., Dec. 4 Ast...S Food and Drug Administration (FDA) has approved ... Extended Release Tablets as adjunctive (add-on) t...epressive Disorder (MDD). SEROQUEL XR is the only ...at both major depressive disorder as adjunctive th...
(Date:12/3/2009)...SO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 /P...y announced the signing of an agreement to provide...oftGenetics, NextGENe software for next-generation...Logo: http://www.newscom.com/cgi-bin/prnh/200904...,s CSO said, "Our team at Ambry has been providing...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Tennessee Drug Card Has Saved Residents Over 247 3 Million 52835 1Tennessee Drug Card Has Saved Residents Over 247 3 Million 52835 2Kansas Delegation Defends NBAF Refutes Washington Post 13213 1Kansas Delegation Defends NBAF Refutes Washington Post 13213 2What Is Keratosis Pilaris 28KP 29 3F 52832 1What Is Keratosis Pilaris 28KP 29 3F 52832 2
...nical workforce, BOULDER, Colo., Oct. 26 Tapestr...d today a plan to focus all,of its resources on ad...d,clinical trials. As part of the strategic plan, ...nt. The Company expects to eliminate 14 positions,... all areas of operations.,All clinical development...
...Par Sciences, Inc., a,privately held biopharmaceut...ay announced molecular biomarker data demonstratin...polymerase) protein in multiple cancers,including ...he first,demonstration of PARP overexpression in s...d to guide the clinical development of the company...
Other Medicine Technology:Tapestry Announces Strategy to Focus on TPI 287 Clinical Program 2Tapestry Announces Strategy to Focus on TPI 287 Clinical Program 3Tapestry Announces Strategy to Focus on TPI 287 Clinical Program 4BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types 2
...h-throughput glass-on-glass coverslipper. The Leic... slides bearing tissue sections or cytopathology s...lips of different standard sizes and all common mo...ariety of slide racks from different suppliers mak...
...c glass coverslipper designed for applications in ...nt is capable of coverslipping up to 400 slides pe...ties. The slide baskets are capable of containing ...ion is made easy via a touchpad. Coverslips of 40,...
...on is the Leica SM2500 sledge microtome with the u...ng is often a viable alternative to standard micro...cially with difficult specimens, where hard and so...men block, the results achieved are truly excellen...
...cian to isolate a treatment region, infuse a physi...ans of oscillation of a Dispersion Wire. The Trell...t balloons near the distal end and infusion holes ... compliant balloons isolate a treatment zone to ma...
Medicine Products: